Abstract
Endocannabinoids are released from postsynaptic neurons and cause retrograde suppression of synaptic transmission. Anandamide and 2-arachidonoylglycerol (2-AG) are regarded as two major endocannabinoids. To determine to what extent 2-AG contributes to retrograde signaling, we generated and analyzed mutant mice lacking either of the two 2-AG synthesizing enzymes diacylglycerol lipase alpha (DGLalpha) and beta (DGLbeta). We found that endocannabinoid-mediated retrograde synaptic suppression was totally absent in the cerebellum, hippocampus, and striatum of DGLalpha knockout mice, whereas the retrograde suppression was intact in DGLbeta knockout brains. The basal 2-AG content was markedly reduced and stimulus-induced elevation of 2-AG was absent in DGLalpha knockout brains, whereas the 2-AG content was normal in DGLbeta knockout brains. Morphology of the brain and expression of molecules required for 2-AG production other than DGLs were normal in the two knockout mice. We conclude that 2-AG produced by DGLalpha, but not by DGLbeta, mediates retrograde suppression at central synapses.
Copyright 2010 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Animals, Newborn
-
Arachidonic Acids / metabolism*
-
Calcium / metabolism
-
Cells, Cultured
-
Cerebellum / cytology
-
Cerebellum / drug effects
-
Cerebellum / physiology
-
Corpus Striatum / cytology
-
Corpus Striatum / drug effects
-
Corpus Striatum / physiology
-
Electric Stimulation / methods
-
Endocannabinoids
-
Excitatory Postsynaptic Potentials / drug effects
-
Excitatory Postsynaptic Potentials / genetics
-
Gene Expression Regulation / genetics
-
Glycerol / analogs & derivatives*
-
Glycerol / metabolism
-
Hippocampus / cytology
-
Hippocampus / drug effects
-
Hippocampus / physiology
-
In Vitro Techniques
-
Inhibitory Postsynaptic Potentials / drug effects
-
Inhibitory Postsynaptic Potentials / genetics
-
Lipoprotein Lipase / classification
-
Lipoprotein Lipase / deficiency
-
Lipoprotein Lipase / metabolism*
-
Methoxyhydroxyphenylglycol / analogs & derivatives
-
Methoxyhydroxyphenylglycol / pharmacology
-
Mice
-
Mice, Inbred C57BL
-
Mice, Knockout
-
Neural Inhibition / drug effects
-
Neural Inhibition / genetics
-
Neural Inhibition / physiology*
-
Neurons / drug effects
-
Neurons / physiology
-
Patch-Clamp Techniques / methods
-
Polyunsaturated Alkamides / metabolism
-
Potassium Chloride / pharmacology
-
Statistics, Nonparametric
-
Synaptic Transmission / drug effects
-
Synaptic Transmission / genetics
-
Synaptic Transmission / physiology*
Substances
-
Arachidonic Acids
-
Endocannabinoids
-
Polyunsaturated Alkamides
-
Methoxyhydroxyphenylglycol
-
Potassium Chloride
-
Lipoprotein Lipase
-
Glycerol
-
Calcium
-
3,4-dihydroxyphenylglycol
-
anandamide